L2 Diagnostics LLC

Woodbridge, CT

UEI
GKA7VH5LFR25
CAGE
43BA5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
37 Seymour Rd, Woodbridge, CT 06525, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $899,471

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Alabama At Birmingham Deciphering and targeting a non-genetic driver pathway in hepatocellular carcinoma R01CA257046 $216,733

Similar vendors

About the company

L2 Diagnostics LLC is a for-profit limited liability company based in Woodbridge, Connecticut, specializing in biomedical research and the development of diagnostics, therapeutics, and vaccines for infectious diseases. The company focuses on innovative medical interventions, particularly targeting complex infectious diseases such as malaria, Chikungunya virus, Lyme disease, and tick-borne pathogens. As a small business registered in SAM.gov, L2 Diagnostics LLC provides advanced research and development services to federal agencies, with a strong emphasis on cutting-edge vaccine and diagnostic technologies.

Through federal contract awards, L2 Diagnostics LLC has primarily engaged in Small Business Innovation Research (SBIR) Program Phase I contracts with the National Institute of Allergy and Infectious Diseases (NIAID). These contracts have included a $599,471 award for developing a therapeutic vaccine platform to boost immune responses in tuberculosis and a $300,000 contract for discovering and validating novel diagnostic biomarkers for malaria. The contracts are designated as total small business set-asides, highlighting the company's role in supporting innovative research by smaller scientific enterprises. While the vendor has not received numerous prime federal contract awards, its SBIR contracts demonstrate a focused approach to developing specialized medical research solutions.

L2 Diagnostics LLC has been substantially more active in federal grant awards, securing multiple project grants from NIAID under the Allergy and Infectious Diseases Research Federal Grant Program. These grants cover a diverse range of infectious disease research, including developing a mosquito-targeted vaccine to disrupt malaria transmission, creating a viral vector-based vaccine against Powassan virus, designing a point-of-care diagnostic test for Babesia microti infection, and exploring multivalent peptide vaccines against malaria. The company has also received grants for innovative research on Chikungunya virus, Lyme arthritis, and tick-borne pathogen transmission prevention. These grants, typically ranging from $281,786 to $299,954, demonstrate L2 Diagnostics LLC's comprehensive approach to addressing complex infectious disease challenges through advanced scientific research and novel technological interventions.

SBA capabilities narrative

Biotechnology R&D, Medical Diagnosotics R&D, Pharmaceutical R&D

Quick answers

Is L2 Diagnostics LLC registered in SAM.gov?

Yes. L2 Diagnostics LLC's SAM.gov registration is active through January 22, 2027.

What is L2 Diagnostics LLC's CAGE code?

L2 Diagnostics LLC's CAGE code is 43BA5, and its Unique Entity ID (UEI) is GKA7VH5LFR25.

How much has L2 Diagnostics LLC received in federal contracts?

Federal contracts obligated $899,471 to L2 Diagnostics LLC in fiscal year 2025.

How does L2 Diagnostics LLC rank among federal contractors?

L2 Diagnostics LLC ranked #85 in PSC AN11 in FY2025.

What is L2 Diagnostics LLC's most recent federal award?

L2 Diagnostics LLC's most recent federal grant award is A viral vector-based vaccine to induce humoral and cellular immune protection against powassan virus in a tick… (R41AI188982), from National Institute of Allergy and Infectious Diseases (NIH), on September 23, 2025.

On GovTribe

See L2 Diagnostics LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe